i.aspTroClose 1200™ 2.0 Multicenter Clinical Demonstration Application Officially Launched
In March 2026, the global exclusive Class III innovative medical device, “TroClose 1200™ 2.0,” from Lujian Technology, officially kicked off its clinical demonstration application at Qilu Hospital Qingdao Campus in Shandong. This was followed by the simultaneous launch of multicenter clinical verification at Nanchong Central Hospital, Chongqing Medical University First Affiliated Hospital, and other institutions.
As the first clinical demonstration of this internationally leading device in China, the launch event attracted over 40 experts and project members from departments such as Gynecology and Urology at Qilu Hospital. During the event, experts engaged in in-depth discussions on product technological innovations, operational standards, and international application experience. It was agreed that TroClose 1200™ 2.0 precisely addresses clinical challenges, and will promote the development of laparoscopic surgery towards greater efficiency, precision, and safety, aiding the upgrade of domestic minimally invasive diagnostic and treatment technologies.
This multicenter launch marks a key milestone in Lujian Technology’s progress in the transformation of high-end medical devices. We will continue to advance clinical demonstration applications, providing China’s clinical solutions with internationally leading technologies that benefit patients and contribute to breakthroughs in medical device innovation and high-quality development.
HOME
PRODUCT
PHONE
